Valence Health-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Valence Health - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013497
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Valence Health is a healthcare company that provides healthcare services. The company offers solutions such as consulting, vision platform, quality measurement, cost and utilization, data collection, contract administration, managed services, and actuarial services. It provides health care solutions that support hospitals, health systems, and physicians. Valence Health service various market needs with clinical integration, population health, quality management, care management, and business intelligence. The company caters its services to hospitals and health systems, children’s hospitals, PHOS and IPAS, accountable care organizations, and consumer operated and oriented plans (CO-OPs). Valence Health is headquartered in Chicago, Illinois, the US.

Valence Health – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Valence Health, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Valence Health, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Valence Health, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Valence Health, Medical Devices Deals, 2011 to YTD 2017 8
Valence Health, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Valence Health, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Valence Health Raises USD15 Million in Venture Financing 10
Valence Health Raises US$30 Million In Venture Financing 11
Partnerships 12
Valence Health Enters Into Co-Development Agreement With Health Choice 12
Valence Health – Key Competitors 13
Valence Health – Key Employees 14
Valence Health – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Valence Health, Pharmaceuticals & Healthcare, Key Facts 2
Valence Health, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Valence Health, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Valence Health, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Valence Health, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Valence Health, Medical Devices Deals, 2011 to YTD 2017 8
Valence Health, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Valence Health Raises USD15 Million in Venture Financing 10
Valence Health Raises US$30 Million In Venture Financing 11
Valence Health Enters Into Co-Development Agreement With Health Choice 12
Valence Health, Key Competitors 13
Valence Health, Key Employees 14
Valence Health, Other Locations 15

★海外企業調査レポート[Valence Health-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Helix Resources Ltd (HLX):企業の財務・戦略的SWOT分析
    Summary Helix Resources Ltd (HRL) operates as a mining and mineral exploration company. The company carries out the business of identification, acquisition, and development of mineral properties. It explores gold, copper, zinc, uranium, nickel, and iron ore properties. HRL's projects include Colleri …
  • Codere S.A.:企業の戦略・SWOT・財務情報
    Codere S.A. - Strategy, SWOT and Corporate Finance Report Summary Codere S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Largan Precision Co Ltd (3008):企業の財務・戦略的SWOT分析
    Largan Precision Co Ltd (3008) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • World Of Medicine GmbH:企業の戦略的SWOT分析
    World Of Medicine GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • TVA Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary TVA Medical Inc (TVA Medical) is a medical device company that designs and manufactures catheter-based systems. The company offers minimally invasive therapies for treatment of end stage renal disease. It offers everlinq, an endovascular device used for creating an AV fistula for hemodialysi …
  • FHI 360:企業の戦略的SWOT分析
    FHI 360 - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Cycle Pharmaceuticals Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Cycle Pharmaceuticals Ltd (Cycle) focuses on the development of pharmaceutical products. It acquires, redevelop, and relaunch pharmaceuticals that have been previously marketed. It spans expertise in improving orphan drugs to treat rare diseases. Cycle’s lead drug product includes NITYR (nit …
  • Volkswagen AG:戦略・SWOT・企業財務分析
    Volkswagen AG - Strategy, SWOT and Corporate Finance Report Summary Volkswagen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • China Resources Pharmaceutical Group Ltd (3320)-製薬・医療分野:企業M&A・提携分析
    Summary China Resources Pharmaceutical Group Ltd (CR Pharma), a subsidiary of China Resources (Holdings) Co Ltd is a pharmaceutical company that offers nutritional supplements. The company offers research and development, manufacture, and distribution of whole drug products. Its products comprise ch …
  • Galapagos NV:企業のM&A・事業提携・投資動向
    Galapagos NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Galapagos NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Abbott India Ltd (ABBOTINDIA):製薬・医療:M&Aディール及び事業提携情報
    Summary Abbott India Ltd (Abbott India), a subsidiary of Abbott Laboratories discovers, develops, manufactures and markets branded generic pharmaceuticals, diagnostics tools, medical devices and nutritionals. Its product portfolio encompasses multi-specialty drugs, vitamins and a comprehensive range …
  • Anthem, Inc.:企業のM&A・事業提携・投資動向
    Anthem, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Anthem, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Concur Technologies, Inc.:企業の戦略的SWOT分析
    Concur Technologies, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Filtronic plc:企業の戦略・SWOT・財務分析
    Filtronic plc - Strategy, SWOT and Corporate Finance Report Summary Filtronic plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • SThree Plc (STHR):企業の財務・戦略的SWOT分析
    Summary SThree Plc (Sthree) is a staffing company that offers permanent and contract staffing business. The company operates through its sectors such as information and communications technology (ICT), energy, engineering, life sciences, banking and finance. Its business brands such as Computer Futu …
  • Gardiner & Theobald LLP:企業の戦略的SWOT分析
    Gardiner & Theobald LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Oriental Hotels Ltd
    Oriental Hotels Ltd - Strategy, SWOT and Corporate Finance Report Summary Oriental Hotels Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Paymark:企業の戦略的SWOT分析
    Paymark - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Barclaycard:企業の戦略・SWOT・財務情報
    Barclaycard - Strategy, SWOT and Corporate Finance Report Summary Barclaycard - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Saladax Biomedical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Saladax Biomedical Inc (Saladax) is a medical equipment company that develops diagnostic tests. The company provides products such as My5-FU, MyPaclitaxel, MyImatinib and MyDocetaxel, among others. Its My5-FU measures and helps physicians to optimize a patient’s exposure to 5-fluorouracil, M …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆